Degenerative Disc Disease Treatment Market, By
Treatment,and End User - Global Industry Insights,
Trends, Outlook, and Opportunity Analysis, 2018-2026
Degenerative disc disease is a spinal condition caused by the breakdown of your intervertebral
discs. The symptoms observed for degenerative disc disease are tingling or numbness in legs or
difficulty walking. This disease is diagnosed with physical examination, through X-rays or
magnetic resonance imaging (MRI). The degenerative disc disease is most commonly seen in
geriatric population and a cause of low back pain and neck pain in adults. The common cases
of back pain among patients occurs at the lower side of the back and is known as lower back
pain. As per American Association of Neurological Surgeons in 2016, 75-85% of people in the
U.S. experience some form of back pain in their life.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1280
Furthermore, depending upon the level of pain, degenerative disc disease can be treated by two
common process which includes non-surgical and spinal fusion. The non-surgical treatments
include medications, physical therapy and chiropractic care. Whereas, spinal fusion is a
procedure used to surgically treat degenerative disc disease.
Recent advances in technology is expected to favor the growth of degenerative disc disease
treatment market in near future.
The recent advances in technology helps the degenerative disc disease treatment market to
augment in near future. For instance, in 2016, according to data published in Journal of
Neurosurgery: Spine, the ProDisc technology has proven clinical efficacy in the U.S. It was also
found. Authors of the study found total disc replacement with ProDisc-C that the procedure is
also cost-effective compared to spinal fusion and recorded an average of US $12,789 in savings
which is more effective than spinal fusion for single-level procedures.
In addition to this, the manufacturers are also focusing on acquisition to adopt and strengthen
the company’s product portfolio. For instance, Centinel Spine in October 2017, has entered into
an asset purchase agreement to acquire the ProDisc Total Disc Replacement portfolio from